November 23, 2016 | Infographic, emerging markets, interactive
An overview of the six most-commonly researched, largest pharma markets in Latin America
The LATAM region’s largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region. With pharmaceutical sales of more than $64bn, it is an attractive market for pharma, however it is also one in which each market differs in terms of opportunities and challenges. Our interactive infographic provides an overview of the six most-commonly researched, largest pharma markets in Latin America.
http://www.researchpartnership.com/news/2016/08/interactive-infographic-latam/
This content was provided by Inizio
Latest Content from Inizio
Evolution from man to machine
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio…
Despite the global advances made in the treatment for asthma, many studies have shown that asthma remains uncontrolled for a large proportion of patients, when assessed according to international guidelines….
Organising a company’s presence, not just logistically, but in terms of delivering key information, data and messages, is a massive part of some people’s workload at this time of year….
Two clients were co-developing a product and needed to understand the patient journey in two areas of oncology, in order to identify the leverage points where they could provide an…
What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?
As part of our continued growth, we are delighted to announce a new intake of 17 Research Analysts and 5 Fieldwork Project Coordinators into our annual market research graduate programme.http://www.researchpartnership.com/news/2016/09/new-graduates-2016/
With the imminent expected approval and launch of a new product, our client needed to conduct global tracking research to understand knowledge, perceptions, awareness and recall around their product and the quality…
The benefits of understanding the patient journey are well documented in mature markets. But in emerging markets the patient journey is less understood. We recently presented a webinar hosted by…
The IBD syndicated market tracker is part of our large auto-immune portfolio
